Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer

Transl Cancer Res. 2020 Mar;9(3):1319-1321. doi: 10.21037/tcr.2020.01.16.

Authors

Whi-An Kwon¹, Ho Kyung Seo²

Affiliations

¹ Department of Urology, Myongji Hospital, Hanyang University College of Medicine, Goyang, Gyeonggi-do, Korea.
² Department of Urology, Center for Urologic Cancer, Hospital/Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Gyeonggi-do, Korea.

No abstract available

Publication types

Editorial
Comment